Daniel Javitt
Daniel Javitt
Departments of Psychiatry and Neuroscience, Nathan Kline Institute & Columbia University
Dirección de correo verificada de
Citado por
Citado por
Recent advances in the phencyclidine model of schizophrenia.
DC Javitt, SR Zukin
The American journal of psychiatry 148 (10), 1301-1308, 1991
Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia
JE Lisman, JT Coyle, RW Green, DC Javitt, FM Benes, S Heckers, ...
Trends in neurosciences 31 (5), 234-242, 2008
From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment
B Moghaddam, D Javitt
Neuropsychopharmacology 37 (1), 4-15, 2012
Multisensory auditory–visual interactions during early sensory processing in humans: a high-density electrical mapping study
S Molholm, W Ritter, MM Murray, DC Javitt, CE Schroeder, JJ Foxe
Cognitive brain research 14 (1), 115-128, 2002
The NKI-Rockland sample: a model for accelerating the pace of discovery science in psychiatry
KB Nooner, SJ Colcombe, RH Tobe, M Mennes, MM Benedict, AL Moreno, ...
Frontiers in neuroscience 6, 152, 2012
Do you see what I am saying? Exploring visual enhancement of speech comprehension in noisy environments
LA Ross, D Saint-Amour, VM Leavitt, DC Javitt, JJ Foxe
Cerebral cortex 17 (5), 1147-1153, 2007
Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia.
DC Javitt, M Steinschneider, CE Schroeder, JC Arezzo
Proceedings of the National Academy of Sciences 93 (21), 11962-11967, 1996
Glutamate and schizophrenia: phencyclidine, N‐methyl‐d‐aspartate receptors, and dopamine–glutamate interactions
DC Javitt
International review of neurobiology 78, 69-108, 2007
Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia
D Umbricht, L Schmid, R Koller, FX Vollenweider, D Hell, DC Javitt
Archives of general psychiatry 57 (12), 1139-1147, 2000
Glutamate as a therapeutic target in psychiatric disorders
DC Javitt
Molecular psychiatry 9 (11), 984-997, 2004
Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia
U Heresco-Levy, DC Javitt, M Ermilov, C Mordel, G Silipo, M Lichtenstein
Archives of general psychiatry 56 (1), 29-36, 1999
When doors of perception close: bottom-up models of disrupted cognition in schizophrenia
DC Javitt
Annual review of clinical psychology 5, 249-275, 2009
Automated analysis of free speech predicts psychosis onset in high-risk youths
G Bedi, F Carrillo, GA Cecchi, DF Slezak, M Sigman, NB Mota, S Ribeiro, ...
npj Schizophrenia 1 (1), 1-7, 2015
The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments
RW Buchanan, DC Javitt, SR Marder, NR Schooler, JM Gold, ...
American Journal of Psychiatry 164 (10), 1593-1602, 2007
Amplitude of low-frequency oscillations in schizophrenia: a resting state fMRI study
MJ Hoptman, XN Zuo, PD Butler, DC Javitt, D D'Angelo, CJ Mauro, ...
Schizophrenia research 117 (1), 13-20, 2010
Multisensory auditory–somatosensory interactions in early cortical processing revealed by high-density electrical mapping
JJ Foxe, IA Morocz, MM Murray, BA Higgins, DC Javitt, CE Schroeder
Cognitive Brain Research 10 (1-2), 77-83, 2000
N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia?
JT Kantrowitz, DC Javitt
Brain research bulletin 83 (3-4), 108-121, 2010
Auditory-somatosensory multisensory processing in auditory association cortex: an fMRI study
JJ Foxe, GR Wylie, A Martinez, CE Schroeder, DC Javitt, D Guilfoyle, ...
Journal of neurophysiology 88 (1), 540-543, 2002
Grabbing your ear: rapid auditory–somatosensory multisensory interactions in low-level sensory cortices are not constrained by stimulus alignment
MM Murray, S Molholm, CM Michel, DJ Heslenfeld, W Ritter, DC Javitt, ...
Cerebral cortex 15 (7), 963-974, 2005
Amelioration of negative symptoms in schizophrenia by glycine.
DC Javitt, I Zylberman, SR Zukin, U Heresco-Levy, JP Lindenmayer
The American journal of psychiatry 151 (8), 1234-1236, 1994
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20